NCT06691087 Sound Perception Study of Hearing-impaired People With Hearing Aids
| NCT ID | NCT06691087 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut Pasteur |
| Condition | Auditory Perception |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2025-04-22 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2025-04-22 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the ETERNEL project will be to study the influence of the perception of a single sound timbre on the understanding of a complex sound scene in hearing-impaired people with hearing aids. This will be done by quantifying the inability to manage a complex sound scene as a function of the timbre of the sounds making it up. The more a sound interferes with understanding the complex sound scene, the more salient that sound is considered to be. In this way, the investigators can determine which timbre dimensions make sounds particularly salient for the hearing impaired.
Eligibility Criteria
Inclusion Criteria: For all participants: * Age between 60 and 75 * Native French speaker * Have given their consent to take part in the study. * Declare that they have an active social life or hobbies that stimulate their cognitive abilities * Have a MOCA score above 26 * No tympano-ossicular dysfunction. * Voice in noise audiometry results showing normal results. For participants with impaired hearing : * Pure tone audiometry showing audiograms of type N3 or N4 and symmetrical between the two ears. * Report having experienced problems with abnormally prominent sound. For participants with normal hearing: \- Pure tone audiometry showing audiograms with losses of less than 30 dBHl. Exclusion Criteria: * Be under guardianship or curatorship, * Be deprived of liberty by judicial or administrative decision, or be under legal protection. * Bear the consequences of an ear infection and/or have a history of an ENT disease that permanently affects hearing or balance (vestibular schwannoma, Ménière's disease, sudden or fluctuating deafness, congenital hypoacusis).
Contact & Investigator
Paul Avan
PRINCIPAL INVESTIGATOR
CERIAH
Frequently Asked Questions
Who can join the NCT06691087 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, up to 75 Years, studying Auditory Perception. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06691087 currently recruiting?
Yes, NCT06691087 is actively recruiting participants. Contact the research team at celine.quinsac@pasteur.fr for enrollment information.
Where is the NCT06691087 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT06691087 clinical trial?
NCT06691087 is sponsored by Institut Pasteur. The principal investigator is Paul Avan at CERIAH. The trial plans to enroll 75 participants.